The Department of Health-Pharmaceutical Division (DOH-PD) in collaboration with the Philippine Pharmacists Association (PPhA) conducted a face-to-face Immunizing Pharmacist Certification Program (IPCP) for Public Health Pharmacists (PHPs) with a theme of, “Empowering Public Health Pharmacists as Frontliner in the midst of pandemic through the delivery of quality health care system for the integration of Universal Health Care.”
To read the full article, kindly click the title.
The Department of Health (DOH), together with other member agencies of the Inter-Agency Committee on Antimicrobial Resistance (ICAMR), culminated the week-long celebration of the Philippine Antimicrobial Awareness Week (PAAW) highlighting the importance of the One Health approach to combat antimicrobial resistance (AMR) fuelled by the COVID-19 pandemic threat.
Traversing towards the realization of quality primary healthcare through free access to essential medicines in support to the goals of the Universal Health Care in Region 1, Laoag City hosted the 17th Policy Dialogue on Universal Health Care and Access to Medicines through a Patient Forum at Sola Hotel, Laoag City, 18 November 2022.
The Philippine Essential Medical Device List (PEMDL) is a compilation of essential medical devices considered as important or necessary for the preventive, diagnostic, therapeutic, or rehabilitative procedures carried out in government health facilities in accordance with Administrative Order No. 2021-0038 “Framework for Philippine Essential Medical Devices List and Price Reference Index”.
Click the title to know more about the PEMDL
Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health (DOH), through the Pharmaceutical Division (PD), crafted the Philippine Medicines Policy which would be implemented from the years 2022 to 2030 to mobilize all key players in the pharmaceutical sector to implement evidence-based policies, improve sustainability programs and leverage best practices throughout the pharmaceutical supply chain.
After three long years and five virtual policy dialogues, the Department of Health (DOH), its partner agencies and offices and the patient support groups and civil society organizations finally convened again face to face during the 16th Policy Dialogue on Universal Healthcare and Access to Medicines held on June 9, 2022 at Cocoon Boutique Hotel, Quezon City.
The Department of Health-Pharmaceutical Division (DOH-PD) conducted a face-to-face Program Implementation Review (PIR) and updates on the different programs of the Pharmaceutical Division in Coron Palawan last April 26-28, 2022 after two years of restrictions from the COVID-19 pandemic.
The DOH Pharmaceutical Division expresses its gratitude to the leadership and concern for poor and vulnerable Filipino patients shown by President Rodrigo Duterte with the passage of two landmark Executive Orders which set maximum retail price to 120 high cost medicines.
The Association of Southeast Asian Nations (ASEAN) Member States, comprising Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam, convened in a two-day online workshop to ensure fair prices and effective financing of medicines and health technologies with the aim to fortify health systems and to achieve wider Universal Health Coverage on April 6-7, 2022.
Generics awareness month celebration
For more information, schedule of events, and related materials for the generic awareness month, please click on the banner.
Observance of the World Antimicrobial Resistance (AMR) Awareness Week (WAAW) 2023 on November 18-24, 2023
The Department of Health announces the release of the department circular in commemoration of World Antimicrobial Resistance Awareness Week (WAAW) 2023, scheduled for November 18-24, 2023. To access detailed information, kindly click the link here.
The Citizens Charter for the Electronic Drug Price Monitoring System contains several steps and processes focused on certification and registration. To learn more about the Charter, please click on the link.
Removal of Metronidazole and Glibenclamide Preparations in the Government-Mediated Access Price (GMAP) List
The Department of Health has removed certain medicines from the Government-Mediated Access Price (GMAP) list. For more details on these changes, you can access the full information of the circular here.
Call for Research Proposal: Procurement of Consulting Services for the Research Study entitled “Process Evaluation and Implementation Review of Executive Order (EO) No. 104 s.2020 and EO NO. 155 s.2021
Procurement of Consulting Services for the Research Study entitled “Process Evaluation and Implementation Review of Executive Order (EO) No. 104 s.2020 and EO NO. 155 s.2021” Click here for the complete information.
Advisory for the Public Consultation on the Draft Administrative Order entitled “Revised Implementing Guidelines on the Electronic Drug Price Monitoring System”
Republic Act No. 9502, otherwise known as the “Universally Accessible Cheaper and Quality Medicines Act of 2008,” mandated the Secretary of Health (SOH)to establish and initiate an electronic price monitoring and regulation system for drugs and medicines which is now known as the Electronic Drug Price Monitoring System (EDPMS).
Click the title to read more about the advisory.
The Department of Health (DOH) informed the Bureau of Internal Revenue (BIR) through Commissioner Caesar R. Dulay the revisions to the list of VAT-Exempt Medicines under Republic Act. 11354 or Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.
Telephone Number: 02-86517800 Loc. 8104
Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City
Email Address: email@example.com